A novel pill shows promising results to decrease the pain and promote a rapid recovery following oral surgery.
A novel pill shows promising results in decreasing the pain and promoting a rapid recovery following oral surgery. The study compared two intravenous nonsteroidal anti-inflammatory drugs (NSAIDs)-diclofenac and ketorolac-along with a placebo.
In this study, 353 patients were given one of these drugs or a placebo following oral surgery.
Total pain relief over 6 hours, as measured by the visual analog scale, was considered the endpoint for this study. Other indicators of efficacy researched included measures of pain intensity and relief, and time to pain relief.
Intravenous diclofenac was given in five different dosages, ranging from 3.75 mg to 75 mg, while ketorolac was given in a 30-mg dose. The study sought to define the minimum dose of intravenous diclofenac that gave an analgesic effect noticeably different from the placebo.
In meeting the endpoint of 6-hour pain relief, diclofenac rated better than the placebo in all but the lowest dosage.
Advertisement
The study has been published in the journal Anesthesia Progress.
Advertisement